TGA Takes Court Action Over Alleged Unlawful Advertising of Peptides and Medicinal Cannabis
The Therapeutic Goods Administration (TGA) has commenced proceedings in the Federal Court of Australia against companies and directors associated with BioV8, Better Leaf Pty Ltd, and Better Life Aussie Pty Ltd over the alleged unlawful advertising of peptides and medicinal cannabis.
According to the TGA, legal action was initiated against Better Leaf Pty Ltd, Better Life Aussie Pty Ltd, and their sole director regarding promotional material published on the company's website and social media platforms. The regulator alleged that this advertising was unlawful because medicinal cannabis products are prescription-only medicines, which are prohibited from being advertised directly to consumers.
In related regulatory actions, the TGA reported that it seized more than $120,000 worth of illicit peptide and anabolic steroid products with assistance from the NSW Police. The seizures took place across two residential premises in New South Wales that were allegedly linked to a social media influencer.
How PressClub produces articles
PressClub uses AI to write news from collected source material, with formatted source text as a fallback. The linked material provides the source’s account; this article does not establish independent verification. Read the source for its own wording and updates.
Read next
Catch up with a briefing, explore coverage, or share this article.
More news to read
Browse more published news. The topic labels show what each article covers.